In compliance with section 17(b) of the Securities Act, we are disclosing that G Medical Innovations Holdings, Ltd. (NASDAQ: GMVD) is a client of TraDigital Marketing Group, Inc. G Medical Innovations Holdings, Ltd. has a 6 month agreement in place, dated August 09, 2021 – February 08, 2022 to compensate TraDigital Marketing Group, Inc. a cash retainer of one hundred thirty-one thousand dollars ($131,000) paid as follows: a monthly cash fee of ten thousand dollars ($10,000), plus seventy-one thousand dollars ($71,000) for publicly disseminating information about G Medical Innovations Holdings, Ltd via website, email, and SMS. G Medical Innovations Holdings, Ltd. has paid TraDigital Marketing Group, LLC a one-time stock fee of fifty thousand shares of common stock, restricted under Rule 144, for investor awareness and digital marketing services. The stock is eligible for sale on 01/15/2022. It is TraDigital’s intention to sell all of our shares once the restriction is lifted on 01/15/2022.
Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. TraDigital Marketing Group, Inc., investor awareness and advisory services include multimedia marketing and other awareness services.